{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:07:26Z","timestamp":1648523246549},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00223-015-0017-2","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:29:15Z","timestamp":1433464155000},"page":"402-411","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attenuation of Antiresorptive Action in Withdrawal of Minodronic Acid for Three Months After Treatment for Twelve Months in Ovariectomized Rats"],"prefix":"10.1007","volume":"97","author":[{"given":"Makoto","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Fracture Intervention Trial Research Group Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","volume":"15","author":"PD Delmas","year":"2004","unstructured":"Delmas PD, Recker RR, Chesnut CH 3rd, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792\u2013798","journal-title":"Osteoporos Int"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering; Committee; HORIZON Pivotal Fracture Trial Steering Committee (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761\u20131771","journal-title":"N Engl J Med"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429\u20131437","journal-title":"Osteoporos Int"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers MJ, Crockett JC, Coxon FP, M\u00f6nkk\u00f6nen J (2011) Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49:34\u201341","journal-title":"Bone"},{"key":"17_CR7","volume-title":"Bisphosphonates in bone disease from the laboratory to the patient","author":"H Fleisch","year":"2000","unstructured":"Fleisch H (2000) Bisphosphonates in bone disease from the laboratory to the patient. Academic Press, San Diego"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/092986711794088335","volume":"18","author":"K Ohno","year":"2011","unstructured":"Ohno K, Mori K, Orita M, Takeuchi M (2011) Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase. Curr Med Chem 18:220\u2013233","journal-title":"Curr Med Chem"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00774-011-0332-2","volume":"30","author":"H Hagino","year":"2012","unstructured":"Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Ohashi Y, Nakamura T, Matsumoto T (2012) Three years of treatment with minodronate in patients with postmenopausal osteoporosis. J Bone Miner Metab 30:439\u2013446","journal-title":"J Bone Miner Metab"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bone.2009.02.016","volume":"44","author":"H Hagino","year":"2009","unstructured":"Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078\u20131084","journal-title":"Bone"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","volume":"17","author":"R Rizzoli","year":"2002","unstructured":"Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, Santora AC 2nd, Kaur A, Peverly CA, Orloff JJ, Alendronate Once-Weekly Study Group (2002) Two-year results of once-weekly administration of alendronate 70\u00a0mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 17:1988\u20131996","journal-title":"J Bone Miner Res"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00198-011-1782-z","volume":"23","author":"R Okazaki","year":"2012","unstructured":"Okazaki R, Hagino H, Ito M, Sone T, Nakamura T, Mizunuma H, Fukunaga M, Shiraki M, Nishizawa Y, Ohashi Y, Matsumoto T (2012) Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. Osteoporos Int 23:1737\u20131745","journal-title":"Osteoporos Int"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1359\/JBMR.040326","volume":"19","author":"KE Ensrud","year":"2004","unstructured":"Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM, Fracture Intervention Trial Long-Term Extension Research Group (2004) Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 19:1259\u20131269","journal-title":"J Bone Miner Res"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","volume":"27","author":"DM Black","year":"2012","unstructured":"Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G, Eastell R (2012) The effect of 3 versus 6\u00a0years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 27:243\u2013254","journal-title":"J Bone Miner Res"},{"issue":"3","key":"17_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","volume":"19","author":"NB Watts","year":"2008","unstructured":"Watts NB, Chines A, Olszynski WP, McKeever CD, McClung MR, Zhou X, Grauer A (2008) Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int 19(3):365\u2013372","journal-title":"Osteoporos Int"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1210\/jc.2011-0412","volume":"96","author":"R Eastell","year":"2011","unstructured":"Eastell R, Hannon RA, Wenderoth D, Rodriguez-Moreno J, Sawicki A (2011) Effect of stopping risedronate after long-term treatment on bone turnover. J Clin Endocrinol Metab 96:3367\u20133373","journal-title":"J Clin Endocrinol Metab"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13\u201320","journal-title":"Am J Med"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","volume":"6","author":"JG Seedor","year":"1991","unstructured":"Seedor JG, Quartuccio HA, Thompson DD (1991) The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6:339\u2013346","journal-title":"J Bone Miner Res"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-004-1612-7","volume":"15","author":"F Bauss","year":"2004","unstructured":"Bauss F, Russell RG (2004) Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing. Osteoporos Int 15:423\u2013433","journal-title":"Osteoporos Int"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00223-002-2015-4","volume":"72","author":"SB Hornby","year":"2003","unstructured":"Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR (2003) Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 72:519\u2013527","journal-title":"Calcif Tissue Int"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2013.02.013","volume":"55","author":"A Kimoto","year":"2013","unstructured":"Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T (2013) Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment. Bone 55:189\u2013197","journal-title":"Bone"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00223-014-9876-1","volume":"95","author":"M Tanaka","year":"2014","unstructured":"Tanaka M, Mori H, Kayasuga R, Ochi Y, Yamada H, Kawada N, Kawabata K (2014) Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 95:166\u2013173","journal-title":"Calcif Tissue Int"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1359\/jbmr.080501","volume":"23","author":"RK Fuchs","year":"2008","unstructured":"Fuchs RK, Phipps RJ, Burr DB (2008) Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats. J Bone Miner Res 23:1689\u20131697","journal-title":"J Bone Miner Res"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF01321840","volume":"53","author":"TJ Wronski","year":"1993","unstructured":"Wronski TJ, Dann LM, Qi H, Yen CF (1993) Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53:210\u2013216","journal-title":"Calcif Tissue Int"},{"key":"17_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","volume":"49","author":"FH Ebetino","year":"2011","unstructured":"Ebetino FH, Hogan AM, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RG (2011) The relationship between the chemistry and biological activity of the bisphosphonates. Bone 49:20\u201333","journal-title":"Bone"},{"key":"17_CR27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bone.2011.01.014","volume":"49","author":"S Cremers","year":"2011","unstructured":"Cremers S, Papapoulos S (2011) Pharmacology of bisphosphonates. Bone 49:642\u2013649","journal-title":"Bone"},{"key":"17_CR28","first-page":"S-33","volume":"18","author":"H Mori","year":"2008","unstructured":"Mori H, Tanaka M, Kayasuga R, Kishikawa K, Ito M (2008) Efficacy of preventive and therapeutic treatments with minodronic acid on ovariectomized rat model of osteoporosis. Clin Pharmacol Ther (Japanese) 18:S-33\u2013S-48","journal-title":"Clin Pharmacol Ther (Japanese)"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bone.2008.07.002","volume":"43","author":"M Tanaka","year":"2008","unstructured":"Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K (2008) Long-term minodronic acid (ONO-5920\/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Bone 43:894\u2013900","journal-title":"Bone"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"17_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0378-4347(93)E0397-9","volume":"652","author":"T Usui","year":"1994","unstructured":"Usui T, Kawakami R, Watanabe T, Higuchi S (1994) Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection. J Chromatogr 652:67\u201372","journal-title":"J Chromatogr"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jor.1100150117","volume":"15","author":"M Kasra","year":"1997","unstructured":"Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas MD (1997) Effects of different estrogen and progestin regimens on the mechanical properties of rat femur. J Orthop Res 15:118\u2013123","journal-title":"J Orthop Res"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2007.04.197","volume":"41","author":"J Fox","year":"2007","unstructured":"Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY (2007) Effects of daily treatment with parathyroid hormone 1\u201384 for 16\u00a0months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Bone 41:321\u2013330","journal-title":"Bone"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bone.2012.11.026","volume":"53","author":"K Nagira","year":"2013","unstructured":"Nagira K, Hagino H, Kameyama Y, Teshima R (2013) Effects of minodronate on cortical bone response to mechanical loading in rats. Bone 53:277\u2013283","journal-title":"Bone"},{"key":"17_CR35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S8756-3282(02)00684-1","volume":"30","author":"M Ito","year":"2002","unstructured":"Ito M, Nishida A, Nakamura T, Uetani M, Hayashi K (2002) Differences of three-dimensional trabecular microstructure in osteopenic rat models caused by ovariectomy and neurectomy. Bone 30:594\u2013598","journal-title":"Bone"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bone.2014.04.003","volume":"64","author":"J Iwamoto","year":"2014","unstructured":"Iwamoto J, Seki A, Sato Y (2014) Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study. Bone 64:88\u201394","journal-title":"Bone"},{"key":"17_CR37","first-page":"S-129","volume":"18","author":"T Usui","year":"2008","unstructured":"Usui T, Kamimura H (2008) Pharmacokinetics of minodronic acid hydrate, a novel bisphosphonate, in rats and dogs. Clin Pharmacol Ther (Japansese) 18:S-129\u2013S-142","journal-title":"Clin Pharmacol Ther (Japansese)"},{"key":"17_CR38","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","volume":"12","author":"SA Khan","year":"1997","unstructured":"Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, Beneton MN, Gertz BJ, Sciberras DG, Holland SD, Orgee J, Coombes GM, Rogers SR, Porras AG (1997) Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 12:1700\u20131707","journal-title":"J Bone Miner Res"},{"key":"17_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/019262339802600215","volume":"26","author":"PG Germann","year":"1998","unstructured":"Germann PG, Ockert D, Heinrichs M (1998) Pathology of the oropharyngeal cavity in six strains of rats: predisposition of Fischer 344 rats for inflammatory and degenerative changes. Toxicol Pathol 26:283\u2013289","journal-title":"Toxicol Pathol"},{"key":"17_CR40","first-page":"i539","volume":"48","author":"K Maita","year":"1986","unstructured":"Maita K, Hirano M, Harada T, Mitsumori K, Yoshida A, Takahashi K, Nakashima N, Kitazawa T, Enomoto A, Inui K, Shirasu Y (1986) An Outbreak of Esophagectasis in F344 Rats Jpn. J Vet Sci 48:i539\u2013i546","journal-title":"J Vet Sci"},{"key":"17_CR41","first-page":"821","volume":"18","author":"Y Naito","year":"2006","unstructured":"Naito Y, Kuroda M, Uchiyama K, Mizushima K, Akagiri S, Takagi T, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T (2006) Inflammatory response of esophageal epithelium in combined-type esophagitis in rats: a transcriptome analysis. Int J Mol Med 18:821\u2013828","journal-title":"Int J Mol Med"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0031-9384(99)00152-3","volume":"68","author":"M Varma","year":"1999","unstructured":"Varma M, Chai JK, Meguid MM, Laviano A, Gleason JR, Yang ZJ, Blaha V (1999) Effect of estradiol and progesterone on daily rhythm in food intake and feeding patterns in Fischer rats. Physiol Behav 68:99\u2013107","journal-title":"Physiol Behav"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jbmr.5650100707","volume":"10","author":"H Yamauchi","year":"1995","unstructured":"Yamauchi H, Kushida K, Yamazaki K, Inoue T (1995) Assessment of spine bone mineral density in ovariectomized rats using DXA. J Bone Miner Res 10:1033\u20131039","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0017-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-015-0017-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0017-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:41:12Z","timestamp":1558683672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-015-0017-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s00223-015-0017-2","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]}}}